Obesity and its related complications continue to be significant challenges for kidney transplant recipients. In previous studies, researchers have reported that brain-derived neurotrophic factor (BDNF) is closely associated with metabolic imbalance and obesity, but the role of BDNF in weight gain after kidney transplant has not been elucidated.
The purpose of this pilot study was to explore the relationship between plasma BDNF levels and weight change. We examined associations between plasma BDNF levels measured at transplantation and 12 months later and measures of weight change during these 12 months in a sample of 55 kidney recipients (mean age of 48 years, 60% male, 56% African American). Of the 55 recipients, 49 had BDNF levels measured at baseline, 33 had BDNF levels measured at 12 months, and 27 had BDNF levels measured at both time points. We found that plasma BDNF levels at baseline (n = 49), but not at 12 months (n = 33), were significantly and positively correlated with the body mass index change (p = 0.037) and percentage weight change (p = 0.036). In addition, average plasma BDNF value at 12 months (307 ± 254 pg/ml) was significantly lower than at baseline (452 ± 345 pg/ml) in the 27 recipients with BDNF levels measured at both time points. Findings from this pilot work suggest that BDNF might serve as a regulator of weight change for kidney transplant related obesity. However, once transplanted, some recipients struggle with other medical issues, including excessive weight gain. During the first year following transplantation, the amount of weight that recipients may gain varies between 6 and 13.5 kg (Cashion et al., 2007; Jezior et al., 2007; Stanfill, Bloodworth, & Cashion 2012 ).
Significant weight gain in a short period of time after transplant not only increases transplant complications, but also negatively affects the possibility of qualifying for another kidney in the event it may be needed (Heaphy et al., 2014) . Potential causes of weight gain after kidney transplant include the use of immunosuppressive medications to protect the newly implanted organ, genetic factors, and lifestyle-related factors, such as food availability (Bloodworth, Ward, Relyea, & Cashion, 2014) Indeed, the induction of satiety (related to energy intake through food) and energy expenditure are two key regulators of overall energy balance. Brain-derived neurotrophic factor (BDNF), a protein found within both the central and peripheral nervous systems, seems to have a crucial role in both sides of energy regulation (Akbarian et al., 2017; Mou et al., 2015; Xu & Xie, 2016) . Evidence suggests that BDNF is an important effector through which the hypothalamic melanocortin pathway controls body weight in adults (Xu et al., 2003) . Several research groups have investigated BDNF changes in end stage renal disease patients and found that hemodialysis sessions for these patients decreased circulating BDNF levels, which might be caused by enhanced oxidative stress induced by hemodialysis, as compared to matched healthy individuals (Marchelek-Mysliwiec et al., 2015; Zoladz et al., 2012) . Still, much is unknown about how circulating BDNF level is involved in energy intake, energy expenditure, and weight change.
To explore the role of BDNF in weight change after kidney transplant, we measured the plasma BDNF levels in 55 recipients at baseline (at the time of transplantation) and 12 months after transplantation to investigate whether circulating BDNF level was correlated with measures of weight changes during this time. This pilot study is the first study of the role of BDNF in obesity after kidney transplantation.
| METHODS

| Design/methods
In this descriptive and correlational study we used plasma BDNF levels and clinical data to determine possible associations between plasma BDNF level and post-transplant changes in BMI and weight at one year following kidney transplantation. Clinical records were obtained from the prospective, longitudinal parent study by Cashion, 2007 in which researchers explored the effect of potential pre-transplant predictors (i.e., genetics, lifestyle) on post-transplant weight gain ) in a single mid-south transplant center in the United States. All study procedures and methods had institutional review board approval, and informed consent was obtained from all participants.
The individuals included in this pilot sub-study also signed a repository consent form for the use of their samples.
| Population
Kidney recipients (n = 66) were recruited from a mid-south regional transplant center (2006) (2007) (2008) (2009) (2010) (2011) and were managed with standardized and center-specific post-transplant protocols. Fifty-five recipients (mean age of 48 ± 13 years, 60% male, 56% African-American) were included for the final analysis after excluding recipients who had more than 10% weight loss at 12-month follow-up. A weight loss of more than 10% was determined to reflect a deviation from the typical expected post-transplantation recovery trajectory. These 55 recipients were grouped into those that had BDNF values only at baseline (n = 49), or at both baseline and 12-months (n = 27). Demographic data in each subgroup have been compared with the parent study population, and no statistically significant difference was detected in the comparison of age, race, sex, and weight related parameters, which indicated that the subgroups were representative of the parent group population. reflect the return to regular eating patterns. Energy intake in kilocalories (kcal) per day, which is the scientific term for calories, was calculated from this information. Energy expenditure was elicited by telephone interview using the well-established Physical Activity Report (Sallis et al., 1985) , and metabolic equivalents (METs) expended per day were calculated from the participants' responses.
| Laboratory measures
Blood from the antecubital vein was collected in sterile serum separator tubes (BD Biosciences, San Jose, CA) at time of transplant and at 12 months follow-up. The anticoagulant tubes were immediately centrifuged at 1,000g for 15 min and stored at −80°C until analysis. Plasma levels of BDNF were measured using a commercially available BDNF immunoassay system kit (R&D System, Minneapolis, MN) following the instructions of the manufacturer. 3 | RESULTS
| Baseline characteristics
The mean age of the 55 kidney recipients was about 48 years old, with 60% men, and 56% African-American. The mean weight at 12 months after transplant increased 3.5 (±5.8) kg, mean percentage weight change was 4.9 (±9.5) %, and mean BMI change was 1.2 (±2.8), with approximately 44% of the participants overweight and 35% obese at baseline, and 36% overweight and 42% obese at 12 months follow up (Table 1) .
| The correlation between weight changes and baseline BDNF levels
To investigate a role of BDNF in post-transplant obesity, we first analyzed a subgroup of 49 recipients who had BDNF values at baseline. This subgroup had similar demographic characteristics (59% men, 55% African American, and mean age of 48.1 years) as the full sample of 55 recipients, with approximately 47% of the participants overweight and 35% obese at transplantation. By 12 months, the mean weight gain was 3.0 (±8.0) kg, mean percentage weight change was 3.3 (±8.9) %, mean change of percentage fat was 3.2 (±4.9) %, and mean BMI change was 1.0 (±2.7), with approximately 35% overweight and 41% obese. The differences of weight (p = 0.011), BMI (p = 0.020), and percent fat (p = 0.002) between baseline and 12 months were significant, but there was no significant difference in the values of energy intake (data not shown).
We further analyzed correlations between baseline BDNF levels and weight-related change in these same 49 recipients. A positive and statistically significant correlation was found between baseline BDNF levels and both percentage weight change and BMI change at 12 months (ρ = 0.302, p = 0.036 and ρ = 0.298, p = 0.037, respectively).
A positive correlation (ρ = 0.33) was also found between the baseline BDNF levels and percentage fat change, but it was not statistically significant given the smaller sample of recipients having data on these variables (n = 29, p = 0.079). The baseline BDNF levels were not correlated with other study measures ( Table 2 ).
3.3 | The BDNF levels at 12 months were significantly decreased compared to those at baseline Twenty-seven recipients had BDNF measurements at both baseline and 12 months. Overall the subgroup resembled the total sample in terms of age, sex, change in weight, percentage body fat, and BMI.
Interestingly, log-transformed BDNF levels at 12 months tended to be lower than that at baseline, with an average decrease of nearly 0.5 SDs (p = 0.036). Of the 27 recipients with BDNF measurements at both time points, 19 (70%) had decreased BDNF values at 12 months follow-up. Although sometimes obesity associated with transplantation is thought to be related to overnutrition or excessive intake of non-nutritive foods, we found no statistically significant changes in dietary intake at 12 months as compared to baseline, p = 0.71. Average daily energy expenditure for these 27 recipients was statistically significantly improved at 12 months, p = 0.004 (Table 3) .
| DISCUSSION
Kidney transplantation is the most common solid organ transplant procedure in the United States. We found that after kidney transplantation, patients had significant weight gain at 12 months, a finding which is consistent with our previous studies (Cashion et al., , 2007 Stanfill et al., 2012) and the findings of others (Beckmann et al., 2017; Costa et al., 2014; Jezior et al., 2007) . Significant weight gain in a short period of time after transplant increases the likelihood of surgical and medical complications, including organ rejection, and disqualifies recipients who may need a second transplantation (Heaphy et al., 2014) . The etiology of weight gain after kidney transplantation continues to be investigated.
Besides its functions in nerve cell survival and adaptive plasticity, the role of BDNF in energy homeostasis has been evaluated recently.
Alterations in the BDNF gene can be considered as genetic determinants of obesity in humans (Akbarian et al., 2017) . In our study, baseline levels of BDNF protein were positively and significantly correlated with percentage weight change at 12 months after kidney transplant. We also found a weak but positive correlation with percentage change in fat. This is an interesting finding as the use of biomarkers that are sensitive and specific enough to identify transplant recipients at risk for significant weight gain is likely to have considerable clinical utility. At-risk recipients could then be targeted for enhanced post-transplant clinical management to prevent subsequent weight gain, which might in turn result in reduced comorbid complications such as hypertension, diabetes, and cardiovascular disorders.
Although some researchers have investigated BDNF levels in end stage renal disease patients and found that hemodialysis session decreased circulating BDNF levels (Marchelek-Mysliwiec et al., 2015; Zoladz et al., 2012) , there is little information about the change of peripheral BDNF in patients undergoing significant weight gain after kidney transplant. In our study, we found that the average BDNF level at 12 months after transplant was significantly lower than that at baseline in 27 recipients in the first year of transplant, a result which is consistent with the previously identified BDNF function in energy homeostasis and obesity (Akbarian et al., 2017; Mou et al., 2015; Xu & Xie, 2016) . Our study is the first to suggest that BDNF might serve as a potential indicator of obesity after kidney transplantation. The underlying mechanisms need to be further elucidated to discover how peripheral BDNF level modulates significant body weight gain after kidney transplantation.
As expected, the baseline plasma BDNF levels measured in our study were comparable to those detected in another study of hemodialysis patients (Shin, Yoon, Chung, Kim, & Kim, 2012) . Our recipients were still hemodialysis patients when the baseline BDNF levels were measured (at time of transplant surgery). Patients with chronic kidney disease present with increased inflammatory activity as kidney function deteriorates. It has been suggested that changes in plasma BDNF might reflect an inflammatory condition in hemodialysis patients (Shin et al., 2012) , which would be improved after successful renal transplantation (Aveles et al., 2010; Cueto-Manzano et al., 2005; Simmons et al., 2005) . Others have reported plasma concentrations of BDNF are influenced by inflammation mediators in patients undergoing major abdominal surgery (Chimienti, Mezzapesa, Rotelli, Lupo, & Pepe, 2012) . Downregulated BDNF levels at 12 months might be an indicator of relief from kidney failure and a reversal of this inflammatory state at 1 year after transplantation. However, it is not yet clear whether circulating BDNF levels could be regulated by immunosuppressive medications in kidney recipients.
Although sometimes obesity associated with transplantation is thought to be related to overnutrition, or excessive energy intake, the average increase in dietary intake at 12 months as compared to baseline (407 cal/day, SD 1892) was accompanied by a significant increase in average daily energy expenditure. For some groups, such an increase in energy expenditure would be enough to offset the average increase in dietary intake and prevent weight gain. But for our sample, this was not the case and weight gain did result. Further study in the mechanisms underlying contributors to weight gain after kidney transplantation is still needed.
Our results suggest that weight gain after kidney transplantation may be multifactorial; indeed, BDNF is a multifunction molecule and 
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